Evidence map›Paper›PMID 25756236›Full record

ArticleNature communications2015

Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.

Jason W-L Eng, Chelsey B Reed, Kathleen M Kokolus, Rosemarie Pitoniak, Adam Utley, Mark J Bucsek, Wen Wee Ma, Elizabeth A Repasky, Bonnie L Hylander

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  18. Article
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jason W-L EngDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Chelsey B ReedDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Kathleen M KokolusDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Rosemarie PitoniakDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Adam UtleyDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Mark J BucsekDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Wen Wee MaDepartment of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Elizabeth A RepaskyDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Bonnie L HylanderDepartment of Immunology, Roswell Park Cancer Institute, Center for Genetics and Pharmacology, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Exploiting thermoregulatory mechanisms to improve radiation therapy of cancerR01CA135368 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A · 2009 to 2013
$1.8M
Analysis of Patient Tumor Responses to Apo2L/TRAILR01CA108888 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A · 2006 to 2010
$1.5M
NCI NIH HHS CA016056NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA108888NCI NIH HHS R01 CA135368NCI NIH HHS T32 CA085183
6 · The paper itself

Abstract

Cancer research relies heavily on murine models for evaluating the anti-tumour efficacy of therapies. Here we show that the sensitivity of several pancreatic tumour models to cytotoxic therapies is significantly increased when mice are housed at a thermoneutral ambient temperature of 30 °C compared with the standard temperature of 22 °C. Further, we find that baseline levels of norepinephrine as well as the levels of several anti-apoptotic molecules are elevated in tumours from mice housed at 22 °C. The sensitivity of tumours to cytotoxic therapies is also enhanced by administering a β-adrenergic receptor antagonist to mice housed at 22 °C. These data demonstrate that standard housing causes a degree of cold stress sufficient to impact the signalling pathways related to tumour-cell survival and affect the outcome of pre-clinical experiments. Furthermore, these data highlight the significant role of host physiological factors in regulating the sensitivity of tumours to therapy.

Indexed as

Gene Expression Regulation, NeoplasticAdrenergic beta-AgonistsAlbuminsAnimalsAntineoplastic AgentsApoptosisbcl-X ProteinCell Line, TumorCisplatinDrug Resistance, NeoplasmHumansIsoproterenolMiceMice, Inbred C57BLMice, SCIDPaclitaxel130-nm albumin-bound paclitaxelAdrenergic beta-AgonistsAlbuminsAntineoplastic AgentsBcl2l1 protein, mouseBcl2 protein, mousebcl-X ProteinCisplatinIsoproterenolPaclitaxelProto-Oncogene Proteins c-bcl-2Receptors, Adrenergic, beta-2TNF-Related Apoptosis-Inducing Ligand

Identifiers

PMID25756236
PMCPMC4471870
OpenAlexW1979835088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.